U.S. Specialty Stores Stock News

Allegiant Travel Company recently reported robust preliminary operating results for October 2025, with scheduled service passenger numbers rising to 1,488,444 from 1,168,344 a year earlier and load factor increasing to 81.9% from 78.5%. This growth in passenger traffic and capacity comes amid ongoing labor tensions and the announcement of new nonstop routes for 2026, highlighting both operational momentum and internal challenges. We'll examine how Allegiant's strong October traffic growth...

Merchants Bancorp recently announced dividends on its common stock and multiple preferred stock series, while Michael F. Petrie, Chairman and CEO, sold 2,177 Series C Depositary Shares after the Q3 2025 earnings report showed mixed results, including improved asset quality. Petrie's insider sales and ongoing substantial ownership highlight executive confidence and raise questions about leadership sentiment amid ongoing strategic initiatives. We'll explore how recent insider sales by the CEO...

Leonardo DRS (DRS) just announced a collaboration with Axon Vision, aimed at integrating AI-driven situational awareness and counter-UAS technologies into U.S. defense platforms. This partnership is designed to deliver automated threat detection and real-time response capabilities. See our latest analysis for Leonardo DRS. Leonardo DRS’s collaboration with Axon Vision follows a year marked by gains and recent volatility. Despite ongoing momentum in the defense sector, the share price return...

Microsoft (MSFT) shares have seen a subtle dip this week, reflecting a slight change in investor sentiment. With the stock price down 1% in the past day, some are revisiting how recent performance compares to the past month. See our latest analysis for Microsoft. Microsoft’s 13.7% total shareholder return over the past year points to a healthy long-term trend. Recent momentum has been mixed, as the 6% one-month share price retreat follows a strong run year to date. With ongoing innovation and...

Harrow, Inc. recently presented at major industry events and secured a key win as its dry eye therapy Vevye replaced Xiidra on the CVS Tier 1 formulary. This change gives Vevye first-line access at the largest pharmacy benefit manager in the US, which could significantly broaden adoption of Harrow’s flagship product. We’ll explore how Vevye’s elevated CVS formulary status may influence Harrow’s growth profile and long-term investment outlook. Rare earth metals are an input to most high-tech...

Copa Holdings, S.A. announced third quarter 2025 operating results, reporting US$913.15 million in revenue and net income of US$173.35 million, with improved passenger traffic and an 88.0% load factor, as well as affirming full-year guidance and issuing preliminary 2026 outlook. Alongside these results, the company ratified a US$1.61 per share dividend and highlighted its confidence in future capacity expansion and cost control. With Copa reaffirming its 2025 guidance and reporting higher...

Coupang (NYSE:CPNG) shares pulled back after the company revealed a major data breach affecting nearly 34 million users. This is the largest such incident in South Korea in more than a decade. The breach has drawn immediate regulatory scrutiny and class action threats. See our latest analysis for Coupang. The news of this historic data leak sent Coupang’s share price tumbling, with a 1-day drop of 5.36% and a 16.64% slide over the past month. Even so, the stock’s year-to-date share price...

In late November 2025, Halper Sadeh LLC, an investor rights law firm, announced an investigation into whether certain officers and directors of Enovix Corp. breached fiduciary duties to shareholders, urging shareholder involvement due to possible limited time to take action. This situation highlights possible ramifications for Enovix’s corporate governance, as shareholder engagement could drive reforms in company oversight or policies. We’ll examine how the ongoing fiduciary duty...

On November 20, 2025, Neurocrine Biosciences announced the publication of a comprehensive peer-reviewed narrative review consolidating over a decade of clinical research on the FDA-approved VMAT2 inhibitors INGREZZA and deutetrabenazine for tardive dyskinesia. The review highlights key differences in pharmacologic, dosing, and clinical profiles between the two treatments, providing practitioners with updated evidence derived from double-blind, placebo-controlled trials and long-term...

Jiayin Group Inc. recently reported its third quarter and nine-month 2025 financial results, with revenue reaching CNY 1.47 billion and CNY 5.13 billion, and net income of CNY 376.49 million and CNY 1.44 billion, respectively, both rising compared to the prior year. The company’s basic earnings per share from continuing operations also showed a clear increase for both the quarter and the year-to-date period. We'll take a look at how Jiayin Group's higher net income growth this quarter...

Wondering if Cintas is trading at a value that makes sense for your portfolio? You’re not alone, as the company’s share price has attracted attention from investors questioning whether the current price is justified. After a steady start to the year, Cintas has seen its stock rise 1.0% in the past week and 1.2% over the last month. It is still down 16.0% over the past year despite impressive multi-year gains. The recent price movement has been influenced by ongoing conversations around the...

On December 1, 2025, CareTrust REIT, Inc. announced it had acquired three senior living communities in Texas for approximately US$40 million, adding 270 assisted living and memory care units to its portfolio as part of its first investment in the senior housing operating portfolio (SHOP) platform. This acquisition not only broadens the company’s direct exposure to the senior housing sector, but also allows CareTrust to participate in property-level performance, with occupancy at the time of...

Trupanion (TRUP) drew attention this week after reporting record subscription adjusted operating income and improved margins, supported by strong net pet additions and higher customer retention. The company also secured a sizable new credit facility and formed new brand partnerships. See our latest analysis for Trupanion. Trupanion’s recent string of positive operating updates has played out against a backdrop of notable volatility. Even with record-high adjusted operating income and new...

In the past week, Monster Beverage reported record quarterly figures, posting net sales, gross profit, operating income, and net income all at new highs, with revenue rising 16.8% year-on-year and international sales making up 43% of total net sales for the first time. This quarter's results mark the company's largest proportion of non-U.S. sales to date, signaling a significant shift toward greater global diversification. We'll explore how Monster Beverage's record international sales...

Expedia Group (EXPE) shares have caught the attention of investors recently, especially after steady gains over the past month. The company’s performance is driving new discussions about its valuation as travel demand recovers. See our latest analysis for Expedia Group. Expedia Group has seen strong momentum recently, highlighted by a 17.7% 1-month share price return and a rally of nearly 40% year-to-date. Major travel names have benefited as demand returns, and Expedia’s 1-year total...

Wingstop recently marked the opening of its 3,000th restaurant globally, expanding its footprint by 50% in just two years and entering six new markets including Australia, Bahrain, Kuwait, Puerto Rico, Saudi Arabia, and The Netherlands as part of its goal to become a top 10 global restaurant brand. This milestone highlights the company's rapid pace of international expansion and its ambition to scale beyond 10,000 locations worldwide in the coming years. We'll explore how Wingstop's swift...

In the third quarter of 2025, Alkermes reported earnings from continuing operations of US$0.49 per share, surpassing expectations as its proprietary products portfolio saw sales rise 16% year over year, driven by demand for Vivitrol, Aristada, and Lybalvi. The company raised its full-year 2025 revenue guidance to a range of US$1.43 billion to US$1.49 billion, highlighting confidence in continued product demand and business momentum. We'll examine how Alkermes' stronger earnings and upgraded...

In late November 2025, several Dorchester Minerals insiders, including the CEO, CFO, and a director, purchased significant amounts of common units following the passing of longtime board member and Audit Committee Chairman C.W. Bill Russell. This series of insider purchases and the leadership transition mark a period of change in both ownership and governance at Dorchester Minerals. We’ll explore how this concentration of insider buying shapes Dorchester Minerals’ investment narrative amid a...

Nuvation Bio (NUVB) announced it is discontinuing the development of its NUV-1511 program due to efficacy concerns. This marks a meaningful shift in the company’s research and development strategy and future drug pipeline. See our latest analysis for Nuvation Bio. The sizable shift in Nuvation Bio’s clinical strategy arrives after an extraordinary streak in its share price, which has soared 204% year-to-date and delivered a total shareholder return of nearly 296% over the past three years...

MGE Energy (MGEE) shares slipped slightly over the past week, continuing a downward trend that has stretched across several months. Even with recent earnings growth, investors seem unimpressed as the stock has lost 14% year-to-date. See our latest analysis for MGE Energy. This latest drop brings MGE Energy’s share price return for the year to a challenging -13.8%, reflecting fading investor momentum despite steady earnings growth and broader sector shifts. Looking at a longer timeframe, the...

New Jersey Resources (NJR) has drawn attention after recent share price movement, with a month gain of 7% compared to a generally steady sector. Investors are now re-examining how current market conditions might influence the company's outlook. See our latest analysis for New Jersey Resources. Momentum has been picking up for New Jersey Resources, with a 1-month share price return of 6.7% contrasting the modest pace from earlier this year. While the stock gave back a bit of ground this week,...

Ever wondered if Equinix is truly a bargain or if the market has just caught up with its story? Let’s break down what is really driving interest in the shares right now. The stock is down 2.0% over the past week and has dropped 13.3% in the last month, translating to a significant 22.3% decline year-to-date, which may point toward shifting market sentiment and evolving risk perceptions. Recent news has focused on Equinix’s ongoing investment in global data center infrastructure and new...

In November 2025, Mahah Human Resources Company announced that it had signed a brand license agreement with ManpowerGroup, granting its subsidiary Growth Avenue Investment Company the rights to operate under the Manpower brand in Saudi Arabia, with the deal formalized during the U.S.-Saudi Investment Forum in Washington, D.C. This agreement gives ManpowerGroup expanded access to the Saudi market through a local partner experienced in workforce localization and professional talent...

Western Alliance Bancorporation recently disclosed it had filed a lawsuit against Cantor Group V LLC, alleging borrower fraud related to collateral loans, which prompted further scrutiny by external parties. This led Rosen Law Firm to announce an investigation into potential securities claims, reflecting heightened legal and compliance concerns among shareholders and stakeholders. We'll explore how the disclosure of alleged borrower fraud and legal investigations may influence risk factors...